HeartStart FRx and HeartStart HS1 automated external defibrillators 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Philips Healthcare 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2013-12-04
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Press release
  • 원인
    Safety alert on philips heartstart frx and heartstart hs1 automated external defibrillators the department of health (dh) today (december 4) drew the public's attention to a safety alert issued by philips healthcare concerning its three models of automated external defibrillators (aeds), namely heartstart frx, heartstart hs1 home and heartstart hs1 onsite, as the devices may be unable to deliver the needed electric shock in a cardiac emergency situation. the dh, through its routine surveillance on medical devices, noticed the above alert from the us food and drug administration. according to philips healthcare, the devices manufactured between 2005 and 2012 could incorrectly indicate that they are ready for use yet be unable to deliver the needed electric shock. according to the local supplier, philips electronics hong kong ltd, the affected models are marketed in hong kong as heartstart frx and heartstart hs1. the dh's enquiries with the supplier revealed that 374 units of heartstart frx and heartstart hs1 have been distributed to hospitals, clinics, schools and other venues. a dh spokesman said, "all owners of the affected aeds are advised to contact their supplier for technical support and advice. they should keep the affected aeds in service until such advice or a replacement is available." "so far, the dh has not received any relevant reports of adverse incidents related to the affected aeds in hong kong," the spokesman added. the company has set up a customer service hotline, 800 969 619, to answer related enquiries. the dh has informed public and private hospitals and relevant associations about the alert and shall continue to liaise with the supplier on the follow-up actions. ends/wednesday, december 4, 2013 issued at hkt 20:46.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Press release: Safety alert on Philips HeartStart FRx and HeartStart HS1 automated external defibrillators
  • Manufacturer

Manufacturer

  • 제조사 모회사 (2017)
  • Source
    DH